Denti.AI Review (2026): The Price Disruptor With Real FDA Clearances

Facts & pricing verified July 3, 2026

Denti.AI is the value pick in dental AI imaging, and not in the “cheap and cheerful” sense — the FDA clearances are real and verifiable in openFDA (K222054 Auto-Chart, K230144 Detect), and Detect holds a distinction neither Pearl nor Overjet matched at its launch: cleared disease detection on both intraoral and panoramic radiographs, an industry first the company earned in 2023.

What it actually does

Four products: Detect (caries, periapical radiolucencies, bone loss on x-rays), Auto-Chart (FDA-cleared automated odontogram charting from radiographs — claimed 97.4% sensitivity and a 70% reduction in charting clicks), Voice Perio (hands-free perio charting, 1M+ charts completed), and Scribe (AI clinical notes with real-time transcription in 20+ languages). A 24/7 AI receptionist rounds out the lineup. Toronto-based, Health Canada licensed, claiming 10,000+ dental professionals and 20+ DSOs.

Pricing — the headline

This is where Denti.AI breaks the category’s rules (The Molar Report, April 2026):

For context, Pearl’s reported entry point is ~$299/month plus a ~$1,500 setup fee. If the detection quality holds for your image volume, the ROI math barely needs a calculator.

Strengths

• Price. An order-of-magnitude undercut on x-ray AI.
• Voice Perio is the best-loved product — Capterra reviewers (4.9/5) describe five-minute hands-free perio charts without pulling an assistant; hygienists are the ones praising it.
• Panoramic + intraoral cleared detection in one product.
• Strong claimed Auto-Chart numbers (97.4% sensitivity / 99.6% PPV) and a claimed 26% lift in identified treatment opportunities from its 24-dentist FDA study.

Weaknesses

• Detection sensitivity trails the leaders — reported caries sensitivity of 65–90% versus 91%+ for expert readers, with documented false positives on periapical lesions. You’re trading some accuracy headroom for the price.
• Voice tools have operatory-reality quirks: reviewers report Voice Perio picking up other people’s voices and measurements, and the AI occasionally assigning findings to the wrong tooth number.
• Tiny public review base (8 Capterra reviews) and a smaller integration/support footprint than Pearl or Overjet.
• Scribe and Auto-Chart pricing are unpublished, which muddies the otherwise transparent value story.

Verdict

For a cost-conscious independent practice that wants FDA-cleared x-ray AI and can live with second-tier sensitivity, Denti.AI at $49/month is the obvious first quote — and Voice Perio is worth evaluating even if you buy your imaging AI elsewhere. Practices where diagnostic sensitivity is the entire point (perio-heavy, high-volume) should still benchmark it against Overjet’s quantified measurements before deciding.

Sources: openFDA 510(k) records, PRNewswire pano clearance, The Molar Report, Capterra, Denti.AI.